Anti-Rat MCP-1 (CCL2) 0 ComentariosSubmit a Review Detalles del Producto Nùmero de Catalogo 500-P76 Descripcion Source: Polyclonal Rabbit Preparation: Produced from sera of rabbits pre-immunized with highly pure (>98%) recombinant Rat MCP-1(MCAF). Anti-Rat MCP-1(MCAF) specific antibody was purified by affinity chromatography employing immobilized Rat MCP-1(MCAF) matrix. Immunogen: E.coli derived Recombinant Rat MCP-1 (CCL2) (PeproTech catalog# 400-12) Sandwich ELISA: To detect Rat MCP-1(MCAF) by sandwich ELISA (using 100 μl/well antibody solution) a concentration of 0.5 - 2.0 μg/ml of this antibody is required. This antigen affinity purified antibody, in conjunction with PeproTech’s Biotinylated Anti-Rat MCP-1(MCAF) (500-P76Bt) as a detection antibody, allows the detection of at least 0.2 - 0.4 ng/well of recombinant Rat MCP-1(MCAF). Western Blot: To detect Rat MCP-1(MCAF) by Western Blot analysis this antibody can be used at a concentration of 0.1 - 0.2 µg/ml. Used in conjunction with compatible secondary reagents the detection limit for recombinant Rat MCP-1(MCAF) is 1.5-3.0 ng/lane, under either reducing or non-reducing conditions. Note: Additional applications tested on a lot-to-lot basis. Please contact Technical Support for more information. crossreactivity: Rat References SDS Búsqueda del CoA Product Line Country Of Origin: USA Not for human use. Research Interest Angiogenesis/Cardiovascular Cancer Chemotaxis Immune System Inflammation Neurobiology Wound Healing Allergy product.subtitle.recentcitations Primer autor Mao, L Titulo Epothilone B impairs functional recovery after spinal cord injury by increasing secretion of macrophage colony-stimulating factor. Citar Cell death & disease; 8(11) pge3162 PudMed id 29095439 Primer autor Adamus, G Titulo Systemic immunotherapy delays photoreceptor cell loss and prevents vascular pathology in Royal College of Surgeons rats. Citar Molecular Vision; 18 pg2323-37 PudMed id 22977300 Primer autor Rius, C Titulo Trans- but not cis-resveratrol impairs angiotensin-II-mediated vascular inflammation through inhibition of NF-κB activation and peroxisome proliferator-activated receptor-gamma upregulation. Citar Journal of immunology (Baltimore, Md. : 1950); 185(6) pg3718-27 PudMed id 20709957
